Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the treatment of chronic type C hepatitis. We studied the long-term efficacy of both drugs alone or in combination. In a three-year period, 108 patients were randomized into three treatment arms: (1) IFN alone 3 MU three times a week (N = 49), (2) IFN 3 MU three times a week + UDCA 250 mg twice a day (N = 45), and (3) UDCA alone 250 mg twice a day (N 14). Response was defined as complete normalization of serum ALT. For the responders at the end of six months, the treatment was run to 12 months. Nonresponders (NRs) of the first group were crossed over to combination and NRs of the combination received 6 MU three times a week IFN + UDCA for the next s...
Interferon (IFN) is the only drug that has been approved by the FDA for therapy of chronic hepatiti...
Using interferon-alpha (IFN-a) as the conventional therapeutic antiviral drug, physicians generally ...
Using interferon-alpha (IFN-a) as the conventional therapeutic antiviral drug, physicians generally ...
Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the tre...
Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the tre...
Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the tre...
The purpose of this study was to compare, within a randomized controlled trial, the efficacy of reco...
Abstract: Few data are as yet available on the influence of interferon (IFN) treatment duration on b...
The purpose of this study was to compare, within a randomized controlled trial, the efficacy of reco...
The aims of the study were to evaluate the long-term efficacy and tolerability of different doses of...
Combination therapy with ribavirin and interferon (IFN)-alpha for 6 to 12 months is currently the tr...
The hepatitis C virus (HCV) has been shown to cause progressive and chronic liver damage.1 Interfero...
We studied the clinical course and the effect of alfa interferon treatment in sixty-six patients of ...
We studied the clinical course and the effect of alfa interferon treatment in sixty-six patients of ...
We studied the clinical course and the effect of alfa interferon treatment in sixty-six patients of ...
Interferon (IFN) is the only drug that has been approved by the FDA for therapy of chronic hepatiti...
Using interferon-alpha (IFN-a) as the conventional therapeutic antiviral drug, physicians generally ...
Using interferon-alpha (IFN-a) as the conventional therapeutic antiviral drug, physicians generally ...
Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the tre...
Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the tre...
Interferon-alpha (IFN) and ursodeoxycholic acid (UDCA) combined have a controversial role in the tre...
The purpose of this study was to compare, within a randomized controlled trial, the efficacy of reco...
Abstract: Few data are as yet available on the influence of interferon (IFN) treatment duration on b...
The purpose of this study was to compare, within a randomized controlled trial, the efficacy of reco...
The aims of the study were to evaluate the long-term efficacy and tolerability of different doses of...
Combination therapy with ribavirin and interferon (IFN)-alpha for 6 to 12 months is currently the tr...
The hepatitis C virus (HCV) has been shown to cause progressive and chronic liver damage.1 Interfero...
We studied the clinical course and the effect of alfa interferon treatment in sixty-six patients of ...
We studied the clinical course and the effect of alfa interferon treatment in sixty-six patients of ...
We studied the clinical course and the effect of alfa interferon treatment in sixty-six patients of ...
Interferon (IFN) is the only drug that has been approved by the FDA for therapy of chronic hepatiti...
Using interferon-alpha (IFN-a) as the conventional therapeutic antiviral drug, physicians generally ...
Using interferon-alpha (IFN-a) as the conventional therapeutic antiviral drug, physicians generally ...